- Home
- ZDAI vs LIXT Comparison
ZDAI vs LIXT Comparison
Compare ZDAI & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- LIXT
- Stock Information
- Founded
- ZDAI 2022
- LIXT 2005
- Country
- ZDAI Hong Kong
- LIXT United States
- Employees
- ZDAI N/A
- LIXT N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- ZDAI Consumer Discretionary
- LIXT Health Care
- Exchange
- ZDAI Nasdaq
- LIXT Nasdaq
- Market Cap
- ZDAI 13.5M
- LIXT 12.4M
- IPO Year
- ZDAI 2024
- LIXT N/A
- Fundamental
- Price
- ZDAI $0.44
- LIXT $4.57
- Analyst Decision
- ZDAI
- LIXT
- Analyst Count
- ZDAI 0
- LIXT 0
- Target Price
- ZDAI N/A
- LIXT N/A
- AVG Volume (30 Days)
- ZDAI 827.4K
- LIXT 121.6K
- Earning Date
- ZDAI 09-19-2025
- LIXT 08-07-2025
- Dividend Yield
- ZDAI N/A
- LIXT N/A
- EPS Growth
- ZDAI N/A
- LIXT N/A
- EPS
- ZDAI N/A
- LIXT N/A
- Revenue
- ZDAI $19,275,673.00
- LIXT N/A
- Revenue This Year
- ZDAI N/A
- LIXT N/A
- Revenue Next Year
- ZDAI N/A
- LIXT N/A
- P/E Ratio
- ZDAI N/A
- LIXT N/A
- Revenue Growth
- ZDAI 43.16
- LIXT N/A
- 52 Week Low
- ZDAI $0.37
- LIXT $0.64
- 52 Week High
- ZDAI $107.36
- LIXT $5.14
- Technical
- Relative Strength Index (RSI)
- ZDAI 32.75
- LIXT 59.46
- Support Level
- ZDAI $0.46
- LIXT $3.20
- Resistance Level
- ZDAI $0.50
- LIXT $4.85
- Average True Range (ATR)
- ZDAI 0.06
- LIXT 0.51
- MACD
- ZDAI -0.00
- LIXT 0.07
- Stochastic Oscillator
- ZDAI 10.23
- LIXT 84.18
About ZDAI Primega Group Holdings Limited Ordinary Shares
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.